Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Vomiting D014839 21 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Peptic Ulcer D010437 19 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Gupta A and Khanna S Repeat Clostridium difficile Testing. 2016 JAMA pmid:27959982
Hanssens L et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. 2016 Prostaglandins Leukot. Essent. Fatty Acids pmid:27154364
Mosquera RA et al. Anti-inflammatory effect of prophylactic macrolides on children with chronic lung disease: a protocol for a double-blinded randomised controlled trial. 2016 BMJ Open pmid:27638496
Kissinger PJ et al. Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis. 2016 Sex Transm Dis pmid:27631353
Nielsen HL et al. Azithromycin vs. Placebo for the Clinical Outcome in Campylobacter concisus Diarrhoea in Adults: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. 2016 PLoS ONE pmid:27893820
Tepper M et al. Mass Treatment with Single-Dose Azithromycin for Yaws. 2016 N. Engl. J. Med. pmid:27626527
Phiri K et al. Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa. 2016 PLoS ONE pmid:27861509
Eckhoff G et al. Mass Treatment with Single-Dose Azithromycin for Yaws. 2016 N. Engl. J. Med. pmid:27626526
Peart JM et al. Sporotrichoid fluctuant nodules. 2016 Cutis pmid:27622258
Elshafie BE et al. The Epidemiology of Trachoma in Darfur States and Khartoum State, Sudan: Results of 32 Population-Based Prevalence Surveys. 2016 Ophthalmic Epidemiol pmid:27841721
Sadatsafavi M et al. The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model. 2016 Am. J. Epidemiol. pmid:27737842
Wang X et al. Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection. 2016 BMC Microbiol. pmid:27341798
Das S et al. Revisit of fluoroquinolone and azithromycin susceptibility breakpoints for Salmonella enterica serovar Typhi. 2016 J. Med. Microbiol. pmid:27221661
Fifer H et al. Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. 2016 N. Engl. J. Med. pmid:27332921
Bacharier LB et al. Early Azithromycin Treatment to Prevent Severe Lower Respiratory Tract Illnesses in Children--Reply. 2016 JAMA pmid:27187309
Gesink D et al. Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance. 2016 Can Fam Physician pmid:27331225
Fleming-Dutra KE et al. Early Azithromycin Treatment to Prevent Severe Lower Respiratory Tract Illnesses in Children. 2016 JAMA pmid:27187308
Kimani J et al. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial. 2016 PLoS ONE pmid:27326859
Morgan R et al. Unusual cause of lymphangitis in a 2-year-old boy. 2016 BMJ Case Rep pmid:27181743
Weckmann M et al. Treatment with rhDNase in patients with cystic fibrosis alters in-vitro CHIT-1 activity of isolated leucocytes. 2016 Clin. Exp. Immunol. pmid:27324468
Kong FY et al. Higher organism load associated with failure of azithromycin to treat rectal chlamydia. 2016 Epidemiol. Infect. pmid:27180823
Oliveira GN et al. Congenital dacryocystocoele with prenatal diagnosis. 2016 BMJ Case Rep pmid:27166005
Oey M and Malhotra P Azithromycin and ceftriaxone combination treatment for relapsed Salmonella Paratyphi A bacteraemia. 2016 J Travel Med pmid:26858276
DeCoster B et al. Expedited Partner Therapy: Clinical Considerations and Public Health Explorations. 2016 AMA J Ethics pmid:27002992
Zhou T et al. Determination of azithromycin residue in pork using a molecularly imprinted monolithic microcolumn coupled to liquid chromatography with tandem mass spectrometry. 2016 J Sep Sci pmid:26854282
Das MC et al. Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin. 2016 Sci Rep pmid:27000525
Saleh A et al. Comparison of adjunctive azithromycin and amoxicillin/metronidazole for patients with chronic periodontitis: preliminary randomized control trial. 2016 Aust Dent J pmid:26836781
Maeda M et al. Study on rectal administration of azithromycin by suppository for pediatric use. 2016 Int J Clin Pharmacol Ther pmid:26833461
Jost C et al. Susceptibility of enterohaemorrhagic Escherichia coli to azithromycin in France and analysis of resistance mechanisms. 2016 J. Antimicrob. Chemother. pmid:26832755
Demczuk W et al. Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. 2016 J. Clin. Microbiol. pmid:26935729
Mohotti JE et al. A case of bilateral endogenous bacterial endophthalmitis from Streptococcus pneumoniae bacteraemia. 2016 Med. J. Aust. pmid:26821111
Trac MH et al. Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. 2016 CMAJ pmid:26903359
Topp E et al. Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field. 2016 Sci. Total Environ. pmid:27096634
Li X et al. Macrolides use and the risk of sudden cardiac death. 2016 Expert Rev Anti Infect Ther pmid:27086751
Arnold FW et al. Macrolide Use and Neutrophil Function/Cytokine Levels in Hospitalized Patients with Community-Acquired Pneumonia: A Pilot Study. 2016 Lung pmid:26553025
Olszewska-Sosińska O et al. Persistence of non-typeable Haemophilus Influenzae in the pharynx of children with adenotonsillar hypertrophy after treatment with azithromycin. 2016 Pathog Dis pmid:26546328
Wakiguchi H et al. Multiple Renal and Splenic Lesions in Cat Scratch Disease. 2016 Jpn. J. Infect. Dis. pmid:26567841
So W et al. Poor outcomes of empiric ceftriaxone ± azithromycin for community-acquired pneumonia caused by methicillin-susceptible Staphylococcus aureus. 2016 Intern Emerg Med pmid:26531307
Amantea D et al. Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype. 2016 Exp. Neurol. pmid:26518285
Manavi K et al. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection. 2016 Int J STD AIDS pmid:26511655
Williams KM et al. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation. 2016 Biol. Blood Marrow Transplant. pmid:26475726
Kasten G et al. Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery. 2016 Drug Dev Ind Pharm pmid:26289002
Lee RA et al. Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center. 2016 J Hosp Med pmid:26287278
Kasten G et al. Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery. 2016 Drug Dev Ind Pharm pmid:26266961
Keenan JD et al. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma. 2016 J Pediatric Infect Dis Soc pmid:27199475
Tous Romero F et al. Acute Infection by Staphylococcus simulans in the Hand of a Man. 2016 JAMA Dermatol pmid:27144675
Horner P et al. 2015 UK National Guideline on the management of non-gonococcal urethritis. 2016 Int J STD AIDS pmid:26002319
Ni C et al. High prevalence of Neisseria gonorrhoeae with high-level resistance to azithromycin in Hangzhou, China. 2016 J. Antimicrob. Chemother. pmid:27090631
Garnier C et al. Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease's lymphadenitis. 2016 Infection pmid:26001741
Wright H et al. Evaluating Guideline-Recommended Antibiotic Practices for Childhood Respiratory Infections: Is It Time to Consider Case-Based Formats? 2016 Clin Pediatr (Phila) pmid:25986442